Key facts
- It has raised $35.2M; the latest was Later Stage VC in Nov 2024.
- Notable investors include Techstars, Impact Assets, SignalFire, Astia, Biovision Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Hawthorne Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Hawthorne Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hawthorne Health
Operator of a clinical trial data platform intended to make trials accessible and convenient for everyone, everywhere. The company's platform combines licensed healthcare professionals with the current connected technology to deliver decentralized clinical trials that are more efficient and more accurate than the traditional trial model, enabling patients to consult with doctors and assist doctors to follow up with their patients anytime.
- Sector
- Healthcare
- HQ
- Walnut Creek, CA, United States
- Founded
- 2015
- Employees
- 146
- Website
- hawthornehealth.com/
- Ownership
- Privately Held (backing)
Hawthorne Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hawthorne Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hawthorne Health in its N-PORT filings yet. We sweep new filings monthly.